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INTRODUCTION
Healthcare systems internationally are 
attempting to counter rises in opioid 
prescribing.1–3 Such rises are largely 
attributed to prescribing for chronic non-
cancer pain,4 where opioids are of limited 
effectiveness and can cause dependence.5 
Prescribed opioids — even weaker opioids 
such as codeine — are associated with 
increased psychosocial problems, 
hospitalisation, and mortality.6–7
The rise in opioid prescribing for 
chronic pain in UK primary care is well 
documented.8–9 Although this rise may 
have peaked,10 one study has shown that 
almost one in 20 adults are prescribed 
long-term opioids.8 Prescribing rates 
are higher in areas of greater social 
deprivation.11 However there is substantial, 
poorly explained variation among practices, 
suggesting that much opioid prescribing 
is driven by GP habits and norms rather 
than patient need. Patients and GPs are 
unsatisfied with opioid prescribing in chronic 
non-cancer pain.12 Patients experience 
repeated consultations that fail to meet their 
needs for pain relief, adequately explain 
their symptoms, and improve their quality 
of life. GPs recognise the shortcomings 
of prescribing and negotiating alternative 
approaches to treatment, but have limited 
access to alternative sources of support.12 
Given accumulating evidence of harm, 
reducing opioid prescribing for chronic 
pain would deliver substantial population 
benefit.
The authors responded to a request for 
help by clinical commissioning groups 
(CCGs) in West Yorkshire by designing and 
delivering a year-long audit and feedback 
intervention, the Campaign to Reduce Opioid 
Prescribing (CROP) (TIDieR Statement 
available13). Audit and feedback is a widely 
used approach that aims to improve patient 
care by reviewing healthcare performance 
against explicit standards and encouraging 
action to address discrepancies between 
desired and actual practice. Although effect 
sizes are generally modest,14 it offers an 
‘upstream’ population approach compared 
with interventions targeting individual 
patients; for example, holistic pain 
management.15 Feedback may prompt GPs 
to think more cautiously when considering 
opioid prescribing (especially for patient 
groups at higher risk of transition to long-
term use, or for stronger opioid prescribing)8 
and encourage medication reviews for 
patients who may not benefit. In a controlled 
interrupted time series analysis, it was 
found that repeated feedback over 1 year 
significantly reduced opioid prescribing — 
particularly in high-risk patient groups — 
without increasing prescriptions for other 
analgesics, saving around £700 000 in 




The rise in opioid prescribing in primary care 
represents a significant public health challenge, 
associated with increased psychosocial 
problems, hospitalisations, and mortality. An 
evidence-based bimonthly feedback intervention 
to reduce opioid prescribing was developed and 
implemented, targeting 316 general practices in 
West Yorkshire over 1 year.
Aim
To understand how general practice staff received 
and responded to the feedback intervention.
Design and setting
Qualitative process evaluation involving semi-
structured interviews, guided by Normalisation 
Process Theory (NPT), of primary care 
healthcare professionals targeted by feedback.
Method
Participants were purposively recruited 
according to baseline opioid prescribing levels 
and degree of change following feedback. 
Interview data were coded to NPT constructs, 
and thematically analysed.
Results
Interviews were conducted with 21 staff from 
20 practices. Reducing opioid prescribing 
was recognised as a priority. While high 
achievers had clear structures for quality 
improvement, feedback encouraged some 
less structured practices to embed changes. 
The non-prescriptive nature of the feedback 
reports allowed practices to develop strategies 
consistent with their own ways of working 
and existing resources. Practice concerns 
were allayed by the credibility of the reports 
and positive experiences of reducing opioid 
prescribing. The scale, frequency, and duration 
of feedback may have ensured a good overall 
level of practice population reach.
Conclusion
The intervention engaged general practice staff 
in change by targeting an issue of emerging 
concern, and allowing adaption to different ways 
of working. Practice efforts to reduce opioid 
prescribing were reinforced by regular feedback, 
credible comparative data showing progress, 
and shared experiences of patient benefit.
Keywords
analgesics, opioid; feedback; general practice; 
Normalisation Process Theory; prescribing; 
process evaluation; qualitative research; quality 
and safety.
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How practices received and responded 
to CROP within the routines, systems, and 
constraints of primary care was evaluated, 
as was the degree to which changes 
became embedded in practice.
METHOD
Design and setting
West Yorkshire in England has a 
socioeconomically and ethnically diverse 
population of approximately 2.2 million 
residents.16 There were 317 general 
practices organised within 10 CCGs in 2016. 
Qualitative, semi-structured interviews 
were conducted with primary care 
professionals responsible for prescribing 
and quality improvement. The process and 
experience of receiving feedback on opioid 
prescribing was explored. Interviews took 
place 14–19 months after the final feedback, 
allowing exploration of both perceived initial 
and sustained impacts. COREQ informed 
the methodology and reporting.17
Intervention
Between April 2016 and March 2017, a total 
of six bimonthly feedback reports were 
delivered (via emailed PDF and post to the 
practice manager) to 316 of 317 general 
practices (one practice abstained from data 
sharing). Practice-specific, comparative 
feedback reports presented overall opioid 
prescribing as well as that for specific 
groups at risk of long-term or strong 
opioid prescribing (see Supplementary 
Figure S1 for the example report). Patients 
with coded cancer, palliative care, or drug 
dependence were excluded.8 Evidence-
informed behaviour change techniques 
were embedded to enhance effectiveness.18 
These included use of peer comparison, 
feedback on behaviour, emphasising the 
credible source of feedback, goal setting, 
and problem solving. The feedback 
advocated reducing opioid prescribing 
and suggested options for action, but was 
‘non-prescriptive’, as responses were 
at practices’ and prescribers’ discretion. 
Practices were also provided with access to 
electronic health record searches, allowing 
them to identify and review individual 
patients. 
Theoretical framework
Data collection and analysis was informed 
by Normalisation Process Theory (NPT), a 
theory of implementation designed to assist 
interpretation of how people in healthcare 
teams individually or collectively embed (or 
not) new work practices.19–20 It includes four 
constructs:
1. Coherence; 
2. Cognitive participation; 
3. Collective action; and 
4.  Reflexive monitoring.
NPT constructs were used as sensitising 
devices to enquire about how general 
practices responded to and acted on the 
feedback (Box 1).20–21
Sampling and recruitment 
Intervention practices were purposively 
sampled using a 2 × 2 sampling frame 
of baseline opioid prescribing and change 
in prescribing during the intervention 
(Table 1). Invitations were emailed to 
practices, with the aim of recruiting around 
five from each group to achieve a total of 
approximately 20 practices. Recruitment 
was monitored against data saturation, and 
the stopping criterion was set as when 
three consecutive interviews elicited no 
new themes or insights.22 Practices were 
asked to nominate interviewees. Each 
participating practice was offered £100 in 
recognition of opportunity costs.
Qualitative data collection
All interviews were conducted by a post-
doctorate pharmacist researcher with 
primary care and qualitative research 
experience, using an NPT-informed topic 
guide (Supplementary Figure S2). Practice 
feedback reports were reviewed with 
participants at interview to help recall and 
reflection. Interviews were audio-recorded 
and transcribed verbatim before analysis. 
Field notes were made immediately after 
each interview.
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How this fits in 
There is international concern about rising 
opioid prescribing, mostly for chronic 
non-cancer pain where population harms 
are likely to outweigh benefits. An audit 
and feedback intervention reduced opioid 
prescribing in UK primary care; however, 
it is not known how general practices 
receive and respond to feedback. This study 
found that practices generally welcomed 
non-judgemental comparative feedback 
addressing an issue of emerging concern, 
which allowed them to respond flexibly 
in mounting a range of organisational 
and clinical actions. Despite growing 
moves towards use of electronic clinical 
dashboards for accessible and continually 
updated data, general practices still value 
simpler formats of feedback to enable 
sharing within teams.
Data analysis
Data were collected and analysed inductively 
in the light of NPT,20 and thematic analysis 
was used to identify recurring themes 
across the data and examine relationships 
between themes.23 While NPT guided 
the analysis, it remained open to other 
notable findings that did not fit within this 
framework. Two authors independently 
coded four transcripts for emerging 
themes, one from each sample group, 
and then compared coding and resolved 
discrepancies. The remaining transcripts 
were coded independently, and overarching 
themes generated by combining and 
comparing codes. 
How codes related to each other was 
mapped, and negative cases were looked 
for to examine similarities and differences 
within and between how practices received 
and acted on feedback reports. Further 
analysis was conducted by charting themes 
in Excel to enable review of practice 
characteristics, opioid prescribing levels, 
and their contribution to themes, and 
identification of when the stopping criterion 
had been met for data saturation. The data 
analysis was completed before the results 
of the interrupted time series analysis were 
known.
Patient and public involvement
The project was developed in consultation 
with the existing primary care research 
patient and public involvement panel.24 
Two panel members helped to refine the 
research question and protocol, including 
by adding a topic guide item on involvement 
of patient participation groups in practice 
quality improvement.
RESULTS
From 148 invitations, 20 practices responded 
and were interviewed, representing all 
sample frame groups (Table 1). 
Data saturation was reached after 
17 interviews, as no new themes were 
elicited from three subsequent interviews 
(Supplementary Figure S3). A second 
person joined one interview, making 
21 interviewees: 12 GPs, four practice 
managers, three practice pharmacists, one 
operations manager, and one IT manager, 
from nine out of 10 CCGs. Interviews lasted 
30–40 minutes and all were conducted in 
general practices. Supplementary Table S1 
summarises practice characteristics and 
reported actions on opioid prescribing.
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Box 1. Normalisation Process Theory constructs and components20 interpreted for the data collection and 
evaluation of CROP
NPT constructs NPT components and interpretation for CROP
Coherence Differentiation Communal specification Individual specification Internalisation
How do participants How does CROP differ with Does the practice team have a What work has been done Has the practice attributed worth 
understand and attribute what is currently done shared understanding of CROP? individually to understand to the CROP project? 
value to CROP? in practice?  CROP?
Cognitive participation Initiation Enrolment Legitimation Activation
Enrolment and What, if any, were the key How were others persuaded to How have they ensured CROP What has been done to sustain 
engagement of individuals drivers for engagement  take part? Was there buy-in? fits with values and ways of change in practice? 
and groups with CROP?  working?
Collective action Interactional workability Relational integration Skill set workability Contextual integration
Organising and doing How was CROP How was confidence and Who did the work, and how was What resource work was done to 
the work operationalised? accountability built and  it allocated? enact CROP? 
  maintained?
Reflexive monitoring Systematisation Communal appraisal Individual appraisal Reconfiguration
Reflecting on progress How has it been determined What group evaluation has there How has CROP affected them as Has the team redefined or 
and making necessary  how effective CROP is in been of the worth of CROP? an individual, and impact on modified practices after 
adjustments practice?  other work? appraisal?
CROP = Campaign to Reduce Opioid Prescribing. NPT = Normalisation Process Theory.
Table 1. Number of practices recruited from the 316 intervention 
practices using the 2 × 2 sampling frame based on initial opioid 
prescribing, and change in prescribing over the intervention year
 Change in prescribing
  Above average Below average  
  reduction reduction or increase
Initial prescribing Above average 4  4 
 Below average 6  6
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Most practices reported actions to reduce 
opioid prescribing, including those that did 
not reduce opioid prescribing during the 
intervention. This analysis suggested no 
indication of a relationship between NPT 
components and practice characteristics 
(that is, list size, role, initial opioid prescribing 
level, and changes in prescribing). 
Supplementary Table S2 summarises 
the coding under NPT components and 
illustrates the wide range of practice 
responses to feedback. The findings are 
then presented under the themes in the 
text. NPT highlighted five themes: deciding 
to act, engaging the team, flexibility in 
responding, overcoming challenges, and 
realising benefits. 
Two further themes were identified: getting 
the intervention into general practices and 
feedback report format.
Deciding to act
The feedback intervention was reported as 
generally well received, with recognition that 
reducing opioid prescribing was a clinical 
priority. Most participants said they had not 
considered acting on opioid prescribing 
previously, while those who had suggested 
that the feedback helped motivate and focus 
effort:
‘Although we were relatively low in the figures, 
it felt like we weren’t doing any rational 
prescribing and it’s important.’ (Participant 
[P]1 [GP, lower prescribing practice, reduced 
prescribing])
Participants reported that reviewing 
feedback and finding high doses of 
prescribed strong opioids, against a 
background of ongoing media coverage of 
opioid-related harm, highlighted the need 
for action. Graphical practice comparisons 
and observing visible rates of change were 
perceived to reinforce action. They were able 
to report examples of patient benefit from 
reducing and stopping opioids.
Some expressed initial concerns about the 
process, particularly about conflict between 
drivers of clinical excellence and patient 
satisfaction. One participant felt that GP 
overload with competing priorities was a 
factor in their practice not engaging with 
feedback:
‘There are so many different pushes on so 
many different areas. It really has got I believe 
completely silly! I think you can change 
behaviour, but you can’t change behaviour 
when you’re changing 20, 30, 40 things at 
the same time.’ (P16 [GP, lower prescribing 
practice, no change in prescribing])
Engaging the team 
Interviewees described the feedback 
intervention as not only being readily 
assimilated in practices with a clear 
structure for quality improvement, but also 
as encouraging less structured practices 
to make changes. They felt the need for 
enthusiastic leadership, citing different team 
members as taking the lead:
‘It’s finding the enthusiast, yes, it needs 
somebody that can push it and repeat it 
and have ownership of it. Who wants to 
be opioid champ? But it needs somebody 
to encourage, to bully, to run the audit. To 
educate the team to continue the downward 
pressure on reducing it and not initiating 
it and looking at alternatives and making 
everybody opioid aware.’ (P1 [GP, lower 
prescribing practice, reduced prescribing])
Responses suggested that a single 
motivated staff member in a small practice 
led effective implementation, while in 
larger practices a shared vision and joint 
working were important. Also, the content of 
feedback reports helped engage staff when 
discussed at team meetings. Examples 
of team engagement reported included 
identifying ‘quick wins’ to encourage action, 
selected GPs trialling approaches with 
patients initially and reporting back, and 
instigating training.
The feedback reports were perceived to 
provide a clear presentation of evidence, 
with the bimonthly delivery, and evidence of 
Box 2. Case example given by P20 (GP)
'So I still remember one lady I was seeing on a weekly basis actually, she was on MST [morphine sulphate 
tablets slow release], tramadol, modified release as well as tramadol acute, pregabalin, and one more drug. 
She had MS [multiple sclerosis] and she had really bad phases when she got on these drugs and never, 
somebody never took her off! And she just got used to them. 
I said: "You’re very stable now, I can’t say when you’ll relapse again, so if you relapse we don’t have any more 
to give you. You’re just looking at a downward spiral here. So if we can, while you’re feeling better, if you can 
gradually take a few things off or reduce them, we’ve got option to actually use them in the future for, for a 
relapse, or something."
And she thought on it and we started off with just taking off MST, gradually so, very gradual reduction. So I 
was seeing her regularly, if she relapses or she’s very anxious about it. But then as she built up that rapport 
with me would mean so em … she stopped MST. Stopped! I said, ‘OK fine let’s give it a break for a couple of 
months and then restart.’ It was coming to winter pressures time so I felt like let’s focus on core business, 
but we will continue this. 
She came back in spring to me and she said, "I've come off tramadol as well!" She had learned the principles 
and she did it! So I was really impressed.
So now a couple of times when she’s come to see me, she’s said, "Look I’m a changed person! I can focus on 
things! I can … I want to do stuff. I’ve got that enthusiasm. Otherwise I was just a blank person!"
So that was quite interesting. Similarly there are quite a few cases where a few of us can quote patients 
where it’s made a big difference in their lives so yes, it makes a big difference. So we’re quite passionate 
about it.
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change in prescribing reinforcing confidence. 
Practices reported committing to prescribing 
policy changes, despite barriers such as 
patient resistance or resource constraints. 
Participants shared examples of processes 
to sustain changes, including agreement of 
new practice policies, cessation of repeat 
prescribing of opioids for non-cancer pain, 
incorporating the feedback into educational 
sessions, and use of long-term locums who 
could attend clinical meetings:
‘I think everyone’s been quite receptive to 
be honest. Because we knew that things 
were going to have to change. Now we’ve 
got long-term locums so we don’t use as 
many ad hoc if we can help, which helps 
because they come to the clinical meetings.’ 
(P5 [Practice manager, higher prescribing 
practice, reduced prescribing])
Flexibility in responding 
Interviewees reported developing strategies 
that fitted with existing resources and 
ways of working, in response to the non-
prescriptive reports. These included utilising 
practice pharmacists, conducting their own 
searches, or producing patient leaflets (see 
Supplementary Table S2 for details): 
‘We’ve had our own leaflets made up. Really 
educating patients. We’ve had them done 
in colour so it actually, patients know that 
it’s not just a little printed sheet and we 
had it done in five languages.’ (P5 [Practice 
manager, higher prescribing practice, 
reduced prescribing])
Some practices reported identifying further 
resources to fit their needs, for example, 
published guidelines for opioid reduction,25 
or online patient self-help tools.26 
While GPs were considered responsible 
for taking most action, proactively or 
opportunistically, other staff in the team 
such as pharmacists, administrators, 
data managers, physiotherapists, drug 
counsellors, and health trainers were 
involved.
Some participants reported that active work 
to reduce opioid prescribing commenced 
later in, or after, the intervention period. 
Three participants ran the patient searches 
at the time of interview and found that their 
practice had reduced opioid prescribing after 
the intervention year:
‘So we are at 41 now, from 120! We were 
120 [patients prescribed an opioid] at the 
end of that [intervention] year.’ (P17 [GP, 
higher prescribing practice, no change in 
prescribing])
Overcoming challenges
Participants identified risks that they 
mitigated by planning. Reported barriers to 
change included professional differences of 
opinion, competing pressures, large patient 
numbers, and the absence of any financial 
incentives or penalties:
‘We actually had a couple of clinical 
meetings where it got quite heated 
unexpectedly! Around strong opiates. A 
couple of prescribers thought even the 
bottom quartile was far too high! So we 
took all views. We developed a policy and 
procedure around strong opiate prescribing 
for the practice.' (P2 [Practice manager, 
lower prescribing practice, no change in 
prescribing])
Implementation was acknowledged as 
taking time and effort. However, participants 
reported they made change more 
manageable by, for example, staggering 
reviews to manage workload or focusing on 
single high-risk patient groups.
Patient expectations and resistance to 
change, or risking harming the patient 
relationship, were not considered reasons to 
abandon new policies. In fact, interviewees 
suggested that patients were often more 
accepting of the changes than anticipated:
‘I think there were ones [patients] that 
just blank refused, and we had difficult 
conversations with — they were definitely 
the minority. But the majority were pretty 
open to it!’ (P15 [GP, higher prescribing 
practice, no change in prescribing])
The feedback was considered helpful in 
justifying the resources required for extra 
appointments, clinical meetings, and the 
time to complete audits. 
Reports were used as consultation aids. 
One practice reported working with a drug 
counsellor to help patients reduce opioid 
use; another referred patients to a local 
meditation group. 
Some practices expressed a wish for 
further support, including a CCG-funded 
pharmacist, addiction management, and 
useful phrases to use in consultations.
Realising benefits 
Bimonthly reports were perceived as 
allowing practices to regularly evaluate 
progress:
‘Looking at reports and then we actually 
implemented our action plans and we got 
a minus 14%!’ (P11 [IT manager, higher 
prescribing practice, reduced prescribing])
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‘Good reduction. Wow. Nice … And I know 
we’ve put a lot of work into it. And across the 
three practices, I did a lot. But I know that 
here we really hammered it.’ (P8 [Practice 
manager, higher prescribing practice, 
reduced prescribing])
Practices reported continuing to review 
opioid prescribing beyond the intervention 
period, spurred on by recognised 
improvements in high-risk groups (reducing 
prescribing of strong opioids and prescribed 
doses of all opioids). Their teams valued 
tangible evidence of their efforts. Some 
reported using responses to feedback as 
examples of quality improvement for Care 
Quality Commission (CQC) inspections:
‘This has obviously helped us to project it 
to other staff members that, look this is the 
difference. And we need to keep doing it. 
That’s one of the things which we produced 
to CQC as well.’ (P10 [GP, lower prescribing 
practice, reduced prescribing])
One participant described the feedback 
as initiating behaviour and culture change. 
Sharing cases where reducing opioids had 
improved patients’ lives made their team 
‘passionate’ about the work (Box 2). Some 
participants considered that the feedback 
had permanently changed their prescribing 
behaviour.
While some practitioners feared being 
judged, and patients returning in pain, they 
expressed satisfaction in helping patients 
reduce their opioid use. 
Participants expressed disappointment 
whenever opioid prescribing increased 
despite their efforts, but accepted that 
reductions in prescribing would take time 
to show impacts.
Practice gatekeepers
Reports did not always reach targeted staff: 
some participants mentioned missing or 
unseen reports, as consequences of filtered 
practice communications or the sheer 
quantity of communications received. 
One participant described an ‘accidental’ 
find on a coffee table, while others did not 
notice the reports until the third or fourth 
communication:
‘So it was probably opened by one of the 
receptionists or our admin clerks. And 
they thought bin or common room? Bin 
or common room? So initially it didn’t, but 
when a second or maybe a third came, I 
probably saw three or four of them and 
I began to pick them up.’ (P1 [GP, lower 
prescribing practice, reduced prescribing])
Preferences for report formats
Some participants preferred paper copies 
of reports as these allowed sharing and 
discussion at practice meetings. It was 
easier to flick through paper reports, 
and large headings eased identification 
of different sections. Other participants 
preferred emailed PDF copies or to have 
both options, particularly for facilitating 
sharing in larger teams:
'[GPs are] so busy with everything I think 
when you’ve got something so clear, it’s 
like look! We’re there! Therefore we need 
to do something, I think that makes it easy.’ 
(P5 [Practice manager, higher prescribing 
practice, reduced prescribing])
Some participants described accessing 
the searches to help identify the patients 
behind the figures. Repeated feedback was 
described as reinforcing impact, with many 
requesting ongoing updates after the end 
of the project. The perceived authoritative 
content of reports lent credibility and 
supported discussions on reduction with 
patients.
Participants appreciated the tone of the 
reports, highlighting the positive messages 
and the ‘well done’ when they had improved:
‘I don’t think there’s anything in the way it 
was written or presented that made me 
think that I don’t want to do this.’ (P6 
[GP, lower prescribing practice, reduced 
prescribing])
Similarly, when prescribing had not 
fallen, participants generally described 
being encouraged by the messages that 
change might take time rather than being 
criticised. Nevertheless, one interviewee 




This study describes how a feedback 
intervention targeting opioid prescribing 
triggered a range of responses by general 
practices, and largely achieved its goals. 
NPT was found to be useful in understanding 
these responses. Practices understood that 
the feedback focused on patient safety 
rather than cost, and generally found it 
credible (coherence). Feedback appeared 
to be well received and motivating, enabling 
practices to respond in ways that fitted within 
existing resources and quality improvement 
processes (cognitive participation).
While all practices received feedback, 
their responses and subsequent actions 
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appeared to vary considerably, with no 
identical responses. Practice teams that 
met regularly and had structured quality 
improvement processes and a committed 
lead appeared to respond best. However, 
certain aspects of feedback, such as 
suggested action plans, helped practices 
with weaker arrangements (collective 
action). Some practices only started to 
make changes following repeated feedback. 
Practice efforts to reduce opioid prescribing 
were reinforced by regular comparative 
and supportive feedback showing progress 
and shared experiences of patient benefit 
(reflexive monitoring).
The feedback reports did not consistently 
pass practice ‘gatekeeping’ processes and 
were sometimes lost among many other 
communications competing for attention. 
However, the scale, frequency, and duration 
of the feedback intervention probably 
ensured sufficient practice population 
reach.
Strengths and limitations
There is now an abundant literature 
describing problematic opioid prescribing 
in general practices.1–4,6,8–9 To the authors’ 
knowledge, this is the first qualitative study of 
a successful approach supporting practices 
to reduce opioid prescribing. Perspectives 
were gathered from initial higher and lower 
prescribing practices, as well as from those 
that did or did not achieve reductions. 
The study’s use of theory illuminated how 
feedback was assimilated within practices. 
The analysis also demonstrated thematic 
saturation.
Study limitations are acknowledged. First, 
interviews took place at least a year after 
the intervention ended, and therefore were 
prone to recall bias. However, this allowed 
exploration of the degree to which any 
impacts on practice processes had become 
normalised, as well as the identification of 
later responses. Second, study participants 
were self-selecting, thereby probably 
underrepresenting those more resistant to 
change. The purposive sampling included 
practices that did not change prescribing; 
one participant did not recall receiving any 
feedback reports. 
Third, the evaluation relied on reported 
rather than observed changes, and could 
not assess the numbers of practices that 
took deliberate action following feedback. 
However, participants provided evidence of 
action, such as examples of new protocols, 
action plans, or patient information. Fourth, 
the relative impacts of the different feedback 
components were not explored. However, 
interviewees did refer to several behaviour 
change techniques without prompting, 
such as peer comparisons, social influence, 
and action planning. 
Finally, the feedback campaign sought a 
general reduction in opioid prescribing based 
on mounting epidemiological evidence of 
harm. Some reductions in prescribing may 
have caused distress to individual patients. 
However, no interviewees suggested that 
the feedback goals were inappropriate. 
Prescribing decisions were ultimately left 
to clinicians to negotiate with individual 
patients. 
Participants reported surprise at the 
acceptance of change by many patients, and 
patients reporting benefits from reducing 
opioids were a motivating factor.
Comparison with existing literature
Patients and GPs struggle with opioid 
prescribing,12 suggesting involvement 
of complex behaviours, including patient 
engagement.27 This feedback intervention 
engaged practices in undertaking complex 
actions such as gradual dose reduction 
for high opioid users, entailing multiple 
appointments and patient engagement.28
Audit and feedback is modestly 
effective in changing a wider range of 
clinical behaviours,29–31 with a median 
4.3% absolute improvement in processes 
of care (for example, prescribing and 
test ordering). However, there is wide 
variation in effectiveness, with one-
quarter of studies having no or even 
negative effects. This intervention drew on 
evidence-based suggestions for optimising 
feedback effectiveness,32–33 and a previous 
implementation package that reduced 
risky prescribing but did not improve type 
2 diabetes control, blood pressure control, 
or anticoagulation for atrial fibrillation.34–35 
For some targeted behaviours, practices 
may feel ‘overwhelmed’ by the scale of 
work needed and demotivated by the 
apparent lack of improvements in response 
to feedback.35 It was found that practice 
teams perceived and exerted control over 
goal setting and action planning in reducing 
opioid prescribing. The Effective Feedback 
to Improve Primary Care Prescribing Safety 
(EFIPPS) study also showed a clinically 
important reduction in targeted prescribing 
by using evidence-based behavioural 
change techniques to enhance responses 
to feedback.36 
Most actions reported in practices 
that successfully reduced prescribing 
were at organisational level. Changes in 
organisational behaviours may augment 
improvement through a wider, more 
systematic reach than changes in individual 
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clinician behaviour.37 Interventions are also 
more likely to succeed if recipients feel 
like they ‘own’ the feedback, rather than it 
being imposed.37 The present intervention 
may have enhanced ownership by allowing 
practices to respond in ways that fitted 
within their resources and ways of working. 
Feedback is often used in combination 
with other interventions. For example, the 
Data-driven Quality Improvement in Primary 
Care (DQIP) study added educational visits 
and financial incentives to prescribing 
feedback.38 There were indications that the 
education visit was useful, but not essential, 
although it is difficult to disentangle the 
effects of individual components.39 The 
present study found that feedback alone 
engaged practices in action in the study’s 
specific context. 
Individual general practices vary 
substantially in their ability to respond to 
changes in recommended prescribing.40 
This study found that some practices 
acted quickly to implement changes, 
while others reported only noticing and 
acting on feedback reports later or after 
the intervention period. It is therefore 
important to consider possible lag effects 
of interventions when assessing their full 
impact.
Implications for research and practice
Given the widespread rise in opioid 
prescribing, difficulties in predicting 
which patients will respond to opioids, 
and increasing evidence of harms,41 this 
study suggests feedback interventions 
can encourage judicious prescribing and 
monitoring. The intervention was well 
received and allowed a range of legitimate 
responses according to practice contexts 
and resources. When delivering feedback, 
careful attention to engagement of practice 
gatekeepers may increase subsequent 
engagement and fidelity. External coverage 
of trends and harms were cited as either 
encouraging practices to begin responding 
to feedback, or motivated continuation. This 
study suggests the wider acceptability and 
perceived value of feedback, targeting areas 
of emerging or established concern beyond 
opioid prescribing. 
Practices generally welcomed the paper 
and emailed report formats that enabled 
subsequent sharing. There are growing 
moves towards use of electronic clinical 
dashboards for feedback that allow 
accessible and continually updated data. 
Dashboards may improve adherence to 
recommendations and improve patient 
outcomes but may also cause user fatigue, 
inadvertently increase barriers to data 
access (for example, if password protected), 
and may fall out of use without regular 
prompts.42
This evaluation took place under ‘real 
world’ conditions, increasing confidence in 
generalisability to routine general practice 
settings. There is scope for enhancing 
feedback effectiveness by optimising the 
content, format, and delivery of feedback, 
although there is continuing uncertainty on 
how best to optimise feedback in routine 
service development.43 Further effectiveness 
studies with parallel process evaluations are 
needed, to optimise feedback components 
and to clarify the contexts in which feedback 
is most likely to work.
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